Combined cytotoxic and genotoxic effects of ochratoxin A and fumonisin B1 in human kidney and liver cell models. (October 2020)

• Record Type: Journal Article
• Authors: Pinhão, M.; Tavares, A.M.; Loureiro, S.; Louro, H.; Alvito, P.; Silva, M.J.
• Is Part Of: Toxicology in vitro. Volume 68(2020)
• Publication Date: 2020-10
• Subjects: Ochratoxin A -- Fumonisin B1 -- Liver and kidney toxicity -- Genotoxicity -- Interactive effects; OTA Ochratoxin A -- MoA Mode of Action -- IARC International Agency for Research on Cancer -- FB1 Fumonisin B1 -- CA Concentration Addition -- IA Independent Action -- FPG Formamidopyrimidine DNA glycosylase -- DMSO Dimethyl sulfoxide -- DPBS Dulbecco's Phosphate-Buffered Saline -- DMEM Dulbecco's Modified Eagle Medium -- FBSi heat-inactivated fetal bovine serum -- HEPES hydroxyethyl-piperazineethane-sulfonic acid buffer -- MTT 3-[4, 5-dimethylthiazole-2-yl]-2, 5-diphenyltetrazolium bromide -- BSA bovine serum albumin -- EMS ethyl methanesulfonate -- ANOVA Analysis of Variance -- SS sum of squares -- DR Dose-ratio dependent -- DL Dose-level dependent -- ROS Reactive Oxygen Species; Toxicity testing -- In vitro -- Periodicals; Toxicology -- Periodicals; 615.9
• DOI: 10.1016/j.tiv.2020.104949
• Languages: English
• ISSNs: 0887-2333

Abstract

Abstract: Food products can be contaminated by several fungi species and each species may produce different mycotoxins, leading to human combined exposure. Although predictions about the joint toxic effects of mycotoxins can be made from their individual toxicities, experimental data is still limited to allow a reliable hazard assessment. Thus, this study aimed to characterize the combined cytotoxic and genotoxic effects of ochratoxin A (OTA) and fumonisin B1 (FB1 ) in cell lines representative of their target organs, kidney and liver. Interactions were ascertained using mathematical extensions to the reference models of concentration addition and independent action. Cytotoxicity (MTT assay) data modeling revealed a synergistic pattern for low doses of both FB1 and OTA shifting to antagonism at higher concentration levels, irrespectively of the reference model applied. Concerning genotoxicity assessment, neither OTA nor FB1, individually or in combination, induced a prominent increase in DNA damage (comet assay) or oxidative DNA damage (FPG-comet assay). In conclusion, this study revealed a synergistic cytotoxic effect for OTA and FB1 at low concentration levels. Given that human co-exposure to these two mycotoxins is probable to occur at low doses, these results raise concerns regarding their potential health outcomes that seem to differ from those predicted by an additive model. Highlights: Ochratoxin A significantly induced cytotoxicity in HK-2 and HepG2 cells. Fumonisin B1 did not induce cytotoxicity in HK-2 nor HepG2 cells. Joint effects of both toxins were assessed through the Concentration Addition and Independent Action mathematical models. Synergistic cytotoxic effects were observed at low ochratoxin A and fumonisin B1 concentrations in both cell models.